Kymab Group Limited develops monoclonal antibody therapeutics for the treatment of cancer, inflammat Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut Sign up to read more
Company number
10414057
Incorporated
2016-10-06
Last updated
19 Dec 2019
Registered office
The Eddeva Building (B920), Babraham Research Campus, Cambridge, CB22 3AT, England
These are the directors and secretaries who have left KYMAB GROUP LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.